Piedmont Investment Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-117,156
| Closed | -$7.37M | – | 229 |
|
|
2020
Q1 | $7.37M | Buy |
117,156
+58,944
| +101% | +$3.71M | 0.29% | 80 |
|
|
2019
Q4 | $4.53M | Buy |
58,212
+2,469
| +4% | +$192K | 0.16% | 146 |
|
|
2019
Q3 | $4.09M | Buy |
55,743
+702
| +1% | +$51.5K | 0.16% | 139 |
|
|
2019
Q2 | $3.39M | Sell |
55,041
-654
| -1% | -$40.3K | 0.14% | 161 |
|
|
2019
Q1 | $3.55M | Buy |
55,695
+819
| +1% | +$52.2K | 0.14% | 152 |
|
|
2018
Q4 | $2.8M | Sell |
54,876
-51,717
| -49% | -$2.64M | 0.13% | 156 |
|
|
2018
Q3 | $6.19M | Buy |
106,593
+44,253
| +71% | +$2.57M | 0.26% | 94 |
|
|
2018
Q2 | $3.03M | Buy |
62,340
+10,647
| +21% | +$517K | 0.15% | 148 |
|
|
2018
Q1 | $2.4M | Buy |
51,693
+40,482
| +361% | +$1.88M | 0.06% | 245 |
|
|
2017
Q4 | $421K | Buy |
11,211
+21
| +0.2% | +$789 | 0.01% | 461 |
|
|
2017
Q3 | $408K | Buy |
11,190
+141
| +1% | +$5.14K | 0.01% | 479 |
|
|
2017
Q2 | $435K | Buy |
+11,049
| New | +$435K | 0.01% | 451 |
|
|
2017
Q1 | – | Sell |
-1,824
| Closed | -$57K | – | 479 |
|
|
2016
Q4 | $57K | Buy |
1,824
+1,803
| +8,586% | +$56.3K | ﹤0.01% | 429 |
|
|
2016
Q3 | $843 | Hold |
21
| – | – | ﹤0.01% | 441 |
|
|
2016
Q2 | $698 | Buy |
+21
| New | +$698 | ﹤0.01% | 395 |
|